Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL
Clinical trial NCT04134247 · UNKNOWN
Trial details
- NCT number
- NCT04134247
- Sponsor
- Shandong Provincial Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2021-11-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.